Double-balloon cervical ripening insertion for terminating CSP associated with low morbidity

Published On: 15 Feb, 2024 11:33 AM | Updated On: 14 May, 2024 8:19 AM

Double-balloon cervical ripening insertion for terminating CSP associated with low morbidity

A new study evaluated the efficacy of double-balloon cervical ripening catheter insertion for terminating cesarean scar pregnancy (CSP) before nine weeks of gestation––a potentially life-threatening condition. 

Here, participants diagnosed with CSP underwent a sterile, double-balloon cervical ripening catheter insertion guided by real-time transabdominal ultrasound – which was removed three days later. The control group received systemic methotrexate (MTX) therapy with or without fetal reduction. 

Treatment failed in five cases out of 35 patients in the double-balloon ripening group and 32 in the MTX group. The success rate difference between the two methods was statistically insignificant. While there were significant differences in the time to normal menstruation and the thickness of the myometrium after surgery, no significant difference was observed in the resolution time of β-HCG or pregnancy residue. 

It was concluded that double-balloon cervical ripening insertion is an effective and minimally invasive method for terminating CSP, with acceptable results and low morbidity, including the prevention of bleeding due to its tamponade properties.

Source: Tarafdari A, Hadizadeh A, Irandoost E, Borna S, Ghamari A, GhotbizadehVahdani F.The Journal of Obstetrics and Gynecology of India. 2024 :1-9.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks